Toregem BioPharma

For a society where people are not afraid of losing their teeth

Kyoto, Japan · Founded 2020 · $22.4M raised

Headquarters
Kyoto
Employees
1–10
Founded
2020
Business Model
B2B
Total Funding
$22.4M
Last Round
$2.6M Series AJun 2026
Rounds
4

About

Toregem BioPharma develops regenerative treatments for tooth defects, enabling patients to regrow their own natural teeth. Founded from decades of Kyoto University research, the lead drug TRG035 blocks the USAG-1 protein that suppresses tooth growth. It targets congenital tooth agenesis and edentulous patients, advancing into Phase 2 clinical trials.

Summary

Toregem BioPharma is a Biotech company based in Kyoto, Japan, founded in 2020. It has raised $22.4M in total across 4 rounds, most recently a $2.6M Series A round in Jun 2026. Investors include Tohoku University Venture Partners, Astellas Venture Management and JIC Venture Growth Investments.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundFunding RoundJun 2026
$5.3M

Sign up to see all 4 events

Funding: Series B through Venture Round. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Toregem BioPharma on Indexed.vc
<a href="https://indexed.vc/companies/toregem-biopharma"><img src="https://indexed.vc/api/badge/company/toregem-biopharma" alt="Toregem BioPharma on Indexed.vc" width="260" height="76" /></a>